3rd World Orphan Drug Congress 2012

The 3rd World Orphan Drug Congress is expected to bring together industry leaders from big pharma, biotechs, government and research organizations to address the opportunities and challenges for the commercialization of drugs to treat rare diseases.

Rare Partners is pleased to announce that Marco Prosdocimi, Managing Director of the Company, has been invited as a speaker in the session entitled "Drug Repositioning & Rare Diseases" with the presentation "Potential for repositioning to act as a gateway to openly innovate in the rare disease field for a “nonprofit company”.

website: www.terrapinn.com/2012/world-orphan-drug-congress